Stock Comparison
GH vs TMO
Guardant Health Inc and Thermo Fisher Scientific Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$19.79B
$190.65B
P/E (TTM)
—
28.2
Forward P/E
—
20.6
Price/Sales
18.3
4.2
Price/Book
55.7
3.7
EV/EBITDA
-5.4
19.7
Dividend Yield
—
0.35%
Profitability
Net Margin
-40.10%
15.10%
Operating Margin
-40.20%
17.90%
Return on Equity
-4584.00%
13.50%
Return on Assets
-17.20%
5.00%
Growth (YoY)
Revenue Growth
48.30%
6.20%
Earnings Growth
0.00%
11.30%
Price & Risk
Beta
1.6
0.9
52-Week High
$151.85
$642.71
52-Week Low
$40.35
$399.99
Analyst Target
$144.42
$599.19
Compare GH and TMO your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.